CASI - CASI Pharmaceuticals EPS beats by $0.02 beats on revenue May, 11 2020 07:16 AM CASI Pharmaceuticals Inc. CASI Pharmaceuticals (NASDAQ:CASI): Q1 GAAP EPS of -$0.09 beats by $0.02.More news on: CASI Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...